|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.26 USD | -1.16% |
|
-10.98% | -48.09% |
| Apr. 02 | QuidelOrtho Shares Fall on Decision to Withdraw FDA 510(k) Submission for Savanna RVP4+ Assay | MT |
| Apr. 02 | QuidelOrtho Gets US FDA Clearance For QuickVue COVID-19 Test | MT |
Quidel Corporation reported earnings results for the fourth quarter ended December 31, 2021. For the fourth quarter, the company reported sales was USD 636.87 million compared to USD 809.2 million a year ago. Net income was USD 291.32 million compared to USD 470.13 million a year ago.
Basic earnings per share from continuing operations was USD 6.98 compared to USD 11.14 a year ago. Diluted earnings per share from continuing operations was USD 6.85 compared to USD 10.78 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -48.09% | 2.59B | |
| +4.82% | 1.61B | |
| -12.79% | 1.43B | |
| +22.29% | 1.22B | |
| -14.90% | 979M | |
| -23.61% | 880M | |
| -9.43% | 718M | |
| -17.46% | 687M | |
| +3.77% | 474M | |
| -.--% | 300M |
QUIDELORTHO CORPORATION 
